Professor of Epidemiology (Microbial Diseases) and of Pharmacology
- Acquired Immunodeficiency Syndrome
- Epidemiology
- Foodborne Diseases
- Hepatitis C
- Injections
- Public Health
- Russia
- Vietnam
- Global Health
- HIV Infections
Diarrheal diseases, along with typhoid and paratyphoid fever, are among the leading causes of death among children worldwide. While the introduction of clean water and sanitation infrastructure has drastically reduced the burden of some enteric pathogens in the United States and other developed countries, much of the world still suffers from a high burden of disease. Furthermore, certain pathogens continue to circulate and cause outbreaks closer to home.
Research on enteric diseases in the Department of Epidemiology of Microbial Diseases includes:
The Pitzer Lab focuses on using mathematical and statistical models to describe transmission patterns, estimate the burden, and predict and quantify the impact of interventions targeting enteric pathogens, including rotavirus, Salmonella Typhi, and cholera. The Pitzer lab works closely with collaborators at field sites in Malawi, Bangladesh, and Nepal. Additionally, the Emerging Infections Program works with the Connecticut Department of Public Health and the Centers for Disease Control and Prevention to conduct active surveillance for foodborne illness and to investigate and respond to foodborne outbreaks in the state of Connecticut.
Professor of Epidemiology (Microbial Diseases) and of Pharmacology
Professor of Epidemiology (Microbial Diseases); Director, HPV Working Group at Yale; Director, CT Emerging Infections Program at Yale, Epidemiology of Microbial Diseases
Associate Professor of Epidemiology (Microbial Diseases)
Associate Clinical Professor, Epidemiology of Microbial Diseases
Dr. Matthew Cartter is the State Epidemiologist for the State of Connecticut Department of Public Health. He is an adjunct associate professor in the Department of Community Medicine and Health Care at the University of Connecticut School of Medicine and an associate clinical professor of Epidemiology and Public Health at the Yale University School of Public Health. Dr. Cartter is a past president of the Council of State and Territorial Epidemiologists. His research interests include the history of epidemics.
Dr. Cartter is also the Director of the Connecticut Emerging Infections Program (EIP), a joint effort between the State of Connecticut Department of Public Health, the Yale Department of Epidemiology and Public Health (EPH), and the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. This Centers for Disease Control and Prevention-funded program is one of ten programs nationwide that seek to assess, through population-based surveillance, the public health impact of emerging infectious diseases and to evaluate methods for their prevention and control in the community (CDC EIP webpage).
Clinical Professor of Epidemiology
Research Interests: The epidemiology of infectious diseases of public health import, particularly the relationship between socioeconomic status and these diseases; infectious disease control.
Dr. Hadler currently is a senior infectious disease and medical epidemiology consultant to the Connecticut and Yale Emerging Infections Programs, the New York City Department of Health and Mental Hygiene and the Council of State and Territorial Epidemiologists. He is involved in the description of health disparities using socioeconomic measures, and most projects conducted by the Connecticut and Yale EIPs, emphasis on epidemiology and prevention of human papilloma virus-related disease, influenza, and bacterial intestinal and respiratory infections.
Dr. Hadler’s main research interests are in the epidemiology, prevention and control of infectious diseases of public health importance in the U.S. For 25 years, from 1984-2008, he was the Connecticut State Epidemiologist and director of the state’s infectious disease surveillance and control programs. In that capacity he lead investigations into many infectious disease outbreaks and emerging infectious disease problems such as HIV, multidrug-resistant tuberculosis, West Nile virus, anthrax, SARS, shiga-toxin producing E. coli and MRSA, and evaluated the impact of new vaccines on the epidemiology of their target diseases.